Zituvimet Tablet, Film Coated
Product Images NDC 70710-1787

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvimet (NDC 70710-1787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (87aee237 8917 49eb 84cb 8612a9780af6 01)

Chemical structure of Sitagliptin, the active ingredient in ZITUVIMET tablets containing Sitagliptin and Metformin Hydrochloride. The structure shows the molecular arrangement including trifluoromethyl and piperazine moieties.*

FDA Label Image

Structure (87aee237 8917 49eb 84cb 8612a9780af6 02)

Chemical structure of the active ingredient Sitagliptin in the ZITUVIMET tablet, showing its molecular components and hydrochloride (HCl) salt form.*

FDA Label Image

Graph (87aee237 8917 49eb 84cb 8612a9780af6 03)

A line graph showing the least squares mean change from baseline over 24 weeks for different treatments: placebo, Metformin 1000 mg twice daily, Sitagliptin 100 mg once daily, and combinations of Sitagliptin 50 mg with Metformin 500 mg or 1000 mg twice daily. The y-axis indicates change from baseline, and the x-axis shows time in weeks.*

FDA Label Image

Graph (87aee237 8917 49eb 84cb 8612a9780af6 04)

A line graph comparing the least squares mean change from baseline over 52 weeks between Sitagliptin 100 mg and Glipizide. The x-axis represents weeks, and the y-axis shows the change from baseline with values ranging from 0.0 to -1.5. The graph shows a decline in both treatments initially with gradual changes over time.*

FDA Label Image

Label (87aee237 8917 49eb 84cb 8612a9780af6 05)

Label for ZITUVIMET tablets (sitagliptin and metformin hydrochloride) 50 mg/500 mg film coated tablets. The package contains 60 tablets, labeled for oral use and prescription only. Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. Includes dosage information and storage instructions on the label.*

FDA Label Image

Label (87aee237 8917 49eb 84cb 8612a9780af6 06)

Label for ZITUVIMET tablets containing sitagliptin 50 mg and metformin hydrochloride 1,000 mg per film-coated tablet. The label indicates the product is prescription-only, packaged as 60 tablets, and manufactured by Zydus Pharmaceuticals (USA) Inc. Important storage instructions and dispensing information are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.